Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Android Infringement Trial Possibly In Deadlock: Reports

RELATED NEWS
Trade ORCL now with 

In the Android infringement litigation of Oracle Inc. (ORCL: Quote) against Google Inc. (GOOG), the U.S. District Judge William Alsup, presiding over the trial in San Francisco, sent the 12-member jury home yesterday, to start the trial "fresh" today, Bloomberg said Friday.

A juror in Oracle reportedly raised doubts about not reaching a unanimous verdict, and possibility the panel is deadlocked.

Looking at a Google document that is sealed from public view, Alsup reportedly said Google's Android mobile platform resulted in a net loss for the company in every quarter of 2010, despite a $97.7 million in revenue for the first quarter of the year. The document showed that Google made "a small profit" for the second half of 2011.

The two Silicon Valley tech giants were locked in two years of patent infringement litigation. The Java developer's lawsuit in the U.S. District Court claims that the search engine giant's Android operating system infringes intellectual property rights relating to the programming language. Android is one of the most widely-used operating systems in smartphones.

Oracle, a business hardware and software provider, is reportedly claiming about $1 billion in compensation in the trial that is expected to last up to 10 weeks - likely lasting until the end of June.

In its lawsuit, filed in August 2010, Oracle argues that its possibility of licensing Java to mobile phone makers was undermined by Google, which uses Java intellectual property, and then giving Android away for free.

Google had argued that the technologies involved should not be covered by copyright law. Jurors have to decide whether Google has added something new or functional to Java that is in the public interest.

Oracle shares closed Thursday's regular trading at $29.38 on the Nasdaq, while Google ended at $611.02.

Register
To receive FREE breaking news email alerts for Oracle Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.